InterSystems announces IRIS FHIR Accelerator Service

InterSystems earlier this week unveiled its new IRIS FHIR Accelerator Service.

WHY IT MATTERS
As developers work on HL7 FHIR applications for different healthcare use cases, they need a way to manage the data that fuel them. InterSystems designed this new service as a fully managed, enterprise-grade server – providing developers a secure and scalable repository for storing and sharing.

The goal of the technology, built on InterSystems IRIS data platform, is to simplify data storage across IoMT, electronic health records and research databases, according to Scott Gnau, head of data platforms for InterSystems.

Key features include authorization and authentication pre-built with OpenID Connect and OAuth 2.0 using the Cognito authorization server, which includes intuitive methods to select custom FHIR scopes and allows developers to easily configure access control for users and applications.

Others include API keys that authenticate incoming FHIR requests, a developer interface to help with more efficient testing, and support for the latest HL7 FHIR version R4, including the United States Core Data for Interoperability, or USCDI.

In addition to high availability using mirroring, and continuous updates delivered automatically, the IRIS FHIR Accelerator Services supports batch import of FHIR bundles via secure file transfer protocol, or sFTP, making it easy to get started quickly with app development.

THE LARGER TREND
This is the newest offering from InterSystems’ Smart Data Services, designed to help customers access the company’s database, interoperability and analytics technologies as smaller, flexible, cloud centric, managed services. Another recent example is HealthShare Message Transformation Services for Amazon HealthLake, which was introduced earlier this summer.

ON THE RECORD
“With a solution like InterSystems IRIS FHIR Accelerator Service, developers have the technology they need to harness interoperability and create solutions to reduce costs, improve patient engagement, facilitate better outcomes, and empower their innovation initiatives,” said Don Woodlock, head of healthcare solutions for InterSystems, in a statement.

“With a fully-managed offering like InterSystems IRIS FHIR Accelerator Service, developers don’t have to worry about traditional infrastructure concerns that come with a FHIR server, including backup and restore, maintenance, and high availability,” added Gnau.

Twitter: @MikeMiliardHITN
Email the writer: mike.miliard@himssmedia.com

Healthcare IT News is a HIMSS publication.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Continued Benefit, More Toxicity With Osimertinib-Chemo thumbnail

Continued Benefit, More Toxicity With Osimertinib-Chemo

Please enable cookies. Error 1005 Ray ID: 88e67055d80a4938 • 2024-06-04 08:09:06 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 88e67055d80a4938 • Your IP: 185.124.111.116 •
Read More
Omicron in the U.S.: What to Know thumbnail

Omicron in the U.S.: What to Know

This story was updated on Dec. 22, 2021. Dec. 20 , 2021 -- The Omicron coronavirus variant has been found in dozens of states across the country since it was first identified in South Africa in November, and many may be wondering: Will it upstage Delta and cause a winter surge? Is it still safe to…
Read More
מחקר ב"איכילוב": מנת החיסון הרביעית מגנה מפני הדבקה מקורונה thumbnail

מחקר ב”איכילוב”: מנת החיסון הרביעית מגנה מפני הדבקה מקורונה

תוצאות ראשוניות ממחקר שנערך במרכז הרפואי איכילוב מראות הגנה מפני הדבקה בקורונה החל משבוע לאחר מנת החיסון הרביעית. מחקרים אחרונים שפורסמו בכתבי עת רפואיים תומכים גם הם ביעילות החיסון הרביעי נגד זן האומיקרון. עם זאת, תוצאות ראשוניות שפורסמו בשבוע שעבר ממחקר שנערך במרכז הרפואי שיבא לבדיקת יעילות החיסון הרביעי נגד הקורונה הראו כי המתחסנים אמנם…
Read More
Index Of News